Novel assay detects Zika, differentiates from dengue and other flaviviruses
July 19, 2017Research and Development Zika, assay, biotech, dengue, drugs, healthcare, pharma, pharmaceutical
A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an …
FDA gives approval for Gilead’s hepatitis C therapy
July 19, 2017Research and Development, Sales and Marketing FDA, Gilead, US, Vosevi, biotech, drugs, healthcare, pharma, pharmaceutical
The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …
Drug combinations can boost weight loss, research finds
July 19, 2017Research and Development biotech, drugs, healthcare, obesity, pharma, pharmaceuticals, weight loss
Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …
UK underperforming in cancer care compared to Europe, according to ABPI report
July 18, 2017Research and Development ABPI, Cancer, Pancreatic cancer, biotech, heralthcare, lung cancer, ovarian cancer, pharma, pharmaceutical
According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …
Radius bolsters leadership with appointment of Novo Vet
July 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Radius, biotech, drugs, pharma, pharmaceutical
Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …
Novartis CEO reasserts 2018 growth expectations, discusses Alcon and Sandoz future
July 18, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, biosimilars, biotech, healthcare, joe jimenez, leukaemia, pharma, pharmaceuticals
Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …
FDA gives nod to drug that prevents breast cancer recurrence
July 18, 2017Manufacturing and Production, Sales and Marketing Puma Biotech, biotech, drugs, pharma, pharmaceutical
Puma Biotech has pounced to secure FDA approval for its extended adjuvant treatment for early-stage, HER2-positive breast cancer. The drug, …
Merck to lay off 200 as part of 5-year reorganisation plan
July 18, 2017Manufacturing and Production Merck, biotech, drugs, healthcare, pharma, pharmaceutical
German drug manufacturer Merck has announced its intention to streamline its manufacturing processes across Europe as part of a five-year …
Valeant takes huge loss on previous deal to pay down debts
July 18, 2017Manufacturing and Production, Sales and Marketing Obagi Medical Products, Valeant, biotech, drugs, pharma, pharmaceutical
It is an odd time for Valeant, where selling a part of its business for half of what it paid, …
Pharmafocus wants to hear from you!
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical
We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new …
GSK completes further high-profile staff acquisition
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …
Research may unlock statins cancer-fighting ability
July 17, 2017Research and Development, Sales and Marketing Keele University, biotech, drugs, pharma, pharmaceutical, statins
Many previous studies have shown that statins are able to have an impact on cancer cells but the results have …
What pharma should know about the European Unitary Patent in light of Brexit
July 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical
The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …
Pierre Fabre secures Italian distribution rights for Noventure’s Aprotecol
July 17, 2017Sales and Marketing Aprotecol, Noventure, Pierre Fabre, biotech, colic, drugs, healthcare, pharma, pharmacuetical
Noventure has allied with Pierre Fabre Pharma Italy in a partnership which will see the latter distribute the Spanish start-up’s …
20 million mosquitoes to be released to limit population
July 17, 2017Research and Development, Sales and Marketing Novartis, Verily, biotech, drugs, google, pharma, pharmaceutical
Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …
FDA refuses approval of Amgen osteoporosis drug
July 17, 2017Sales and Marketing Amgen, Evenity, Radial, UCB, biotech, drugs, osteoporosis, pharma, pharmaceutical
Amgen and its development partner UCB have announced that the FDA has issued a complete response letter for the biologics …
AstraZeneca’s Soriot Teva switch scotched
July 17, 2017Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical
The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …
UK government announces £86 million funding as tentative AAR step
July 14, 2017Medical Communications NHS, UK government, biotech, drugs, pharma, pharmaceutical
The UK government has revealed that it will apportion £86 million to help the assessment of new technologies and increase …
Not long after leaving GSK, Andrew Witty dips toes back into water
July 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, G1 Therapeutics, GSK, biotech, drugs, pharma, pharmaceutical
Only a short while after leaving his position as CEO of GSK, it seems Andrew Witty cannot resist getting back …
What Brexit means for drug regulation
July 14, 2017Medical Communications, Sales and Marketing biotech, brexit, drugs, healthcare, pharma, pharmaceuticals, regulation
The pharmaceutical sector is one of the most tightly regulated industries, and most of the rules that govern the daily …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
